What Specialists Are Needed for MPS I Long-Term Care?
At a Glance
Children with MPS I require a multidisciplinary care team led by a metabolic geneticist. Long-term care involves routine surveillance including annual or semi-annual echocardiograms, sleep studies, eye and hearing exams, and specialized cervical spine imaging to prevent severe complications.
In this answer
2 sections
Mucopolysaccharidosis type I (MPS I) is a complex, multisystemic condition, which means it affects many different parts of the body as your child grows [1][2]. Because the condition changes over time, long-term care requires a comprehensive, team-based approach to monitor health, manage symptoms, and prevent complications before they become severe [3][4].
The cornerstone of your child’s care will be a multidisciplinary care team led by a metabolic geneticist [1][5]. This specialist acts as the “captain” of your child’s medical team, expertly coordinating care among various specialists, managing treatments like enzyme replacement therapy (ERT) or monitoring after stem cell transplantation, and ensuring that all routine surveillance is up to date [6][7].
Key Specialists on Your Child’s Care Team
Depending on your child’s specific diagnosis (severe Hurler syndrome versus attenuated Hurler-Scheie or Scheie syndromes) and their individual symptoms, their care team will likely include:
- Metabolic Geneticist: Oversees the big picture, coordinates treatments, and tracks the overall progression of the disease [5][8].
- Cardiologist: Monitors the heart for valve dysfunction and enlargement, which are common early features of MPS I [9][10].
- Pulmonologist / Sleep Medicine Specialist: Manages airway complications and monitors for sleep apnea (breathing pauses during sleep) [4].
- Ophthalmologist: Checks for eye problems like corneal clouding and optic nerve issues [11][12].
- Audiologist & ENT (Ear, Nose, and Throat Specialist): Manages recurrent ear infections and monitors for hearing loss, which is highly prevalent in children with MPS I [13].
- Orthopedist & Neurosurgeon: Monitors the skeleton and spine, particularly looking for dangerous pressure on the spinal cord or brain [2][14].
- Pediatric Anesthesiologist: Because children with MPS I often have complex airways and sensitive necks, any procedure requiring anesthesia or sedation must be handled by an anesthesiologist experienced with MPS I [4][2].
- Developmental Pediatrician & Neuropsychologist: Tracks cognitive and developmental milestones. While severe cognitive decline is primarily seen in the Hurler subtype, all children with MPS I benefit from developmental monitoring to ensure they receive appropriate learning support [1][4].
- Physical (PT) & Occupational Therapists (OT): Manages dysostosis multiplex (progressive bone and joint stiffness) to maximize mobility and daily function [4][3].
- Pediatric Dentist: Dental anomalies and enlarged gums are common in MPS I, requiring specialized routine care that accounts for airway safety [4].
Practical Tip: Managing all these appointments is a full-time job. Ask your metabolic geneticist or hospital to connect you with a Complex Care Coordinator or a social worker to help juggle scheduling and insurance.
Routine Surveillance Tests and Guidelines
Consistent, routine monitoring is the standard of care for all children with MPS I [15][4]. This surveillance detects slow-moving changes in the body so that interventions can happen early [1][16]. Your metabolic geneticist will create a personalized schedule and regularly check routine labs (such as urinary GAG levels) to track disease activity, but standard surveillance generally requires the following tests on an annual or semi-annual (twice a year) basis:
1. Echocardiograms (Heart)
Echocardiograms (ultrasounds of the heart) are required annually or semi-annually to screen for cardiac complications [17][9]. MPS I can cause the heart valves to thicken and leak (valvulopathy), and can lead to progressive abnormalities in the heart muscle [10][18]. Catching these changes early allows cardiologists to adjust medications or plan for surgical interventions if needed [19].
2. Sleep Studies and Lung Tests (Airway/Apnea)
Children with MPS I are at high risk for narrowed airways and obstructive sleep apnea [3][4]. Regular sleep studies (polysomnography) are necessary to monitor how well your child breathes at night. If apnea is detected, your team may recommend interventions like continuous positive airway pressure (CPAP) machines or tonsil removal. As your child grows older and can cooperate, awake Pulmonary Function Tests (PFTs) are often added to track lung capacity [4].
3. Eye Exams
Comprehensive eye exams are needed annually or semi-annually to monitor for corneal opacification (clouding of the clear front part of the eye) and optic nerve sheath abnormalities [20][11]. Without regular monitoring and timely treatment, these issues can lead to significant vision loss [12].
4. Hearing Tests (Audiology)
Because hearing loss is extremely common in MPS I, comprehensive audiological evaluations are recommended annually [13][21]. Keeping track of your child’s hearing is vital for their speech development, learning, and daily communication. If hearing loss is detected, your team can help with hearing aids or ear tubes [13].
5. Cervical Spine Imaging (X-rays and MRIs)
One of the most critical parts of long-term care for MPS I involves monitoring the neck and spine [2][4]. Children with MPS I frequently develop odontoid dysplasia (an underdeveloped bone in the neck) and cervical canal stenosis (narrowing of the spinal canal), which can lead to spinal cord compression and instability [22][23]. Regular cervical spine X-rays and neuroimaging, such as brain and spine MRIs, are required to catch these problems before they cause permanent neurological damage [2][24]. Because MRIs often require sedation in young children, this imaging should always be coordinated by your metabolic geneticist and an experienced pediatric anesthesiologist [2].
Common questions in this guide
Who should lead my child's MPS I care team?
What heart tests are required for MPS I surveillance?
Why does my child need regular sleep studies for MPS I?
Why is specialized anesthesia so important for a child with MPS I?
How often should a child with MPS I get cervical spine MRIs?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How frequently should my child's specific MPS I subtype require updated cervical spine MRIs, and who will coordinate the specialized anesthesia for it?
- 2.Can you refer us to a complex care coordinator or social worker who can help me schedule and manage these multiple specialist appointments?
- 3.What specific cognitive and developmental milestones should we be tracking for my child's subtype, and who will monitor them?
- 4.Who should I contact in an emergency to ensure any surgical or airway interventions are handled by an anesthesiologist experienced with MPS I?
- 5.When should we begin introducing awake Pulmonary Function Tests (PFTs) alongside our regular sleep studies?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (24)
- 1
Clinical outcomes of exclusive enzyme therapy (laronidase) in a cohort of patients with mucopolysaccharidosis type I.
Guffon N, Pettazzoni M, Pangaud N, et al.
Orphanet journal of rare diseases 2025; doi:10.1186/s13023-025-04157-6.
PMID: 41353341 - 2
Neuroimaging and spinal manifestations of mucopolysaccharidosis type I: Insights from a pediatric case.
Boujida N, Jabour S, Elaitari K, et al.
Radiology case reports 2025; (20(12)):5795-5799 doi:10.1016/j.radcr.2025.08.011.
PMID: 40989062 - 3
Challenges in Diagnosing and Managing Hurler Syndrome: A Case Report.
Achiatar LS, Hazoor HB, Adwani R, et al.
Cureus 2024; (16(8)):e67056 doi:10.7759/cureus.67056.
PMID: 39286678 - 4
New recommendations for the care of patients with mucopolysaccharidosis type I.
Bay L, Amartino H, Antacle A, et al.
Archivos argentinos de pediatria 2021; (119(2)):e121-e128 doi:10.5546/aap.2021.eng.e121.
PMID: 33749201 - 5
Acute Illness Protocol for Maple Syrup Urine Disease.
Rodan LH, Aldubayan SH, Berry GT, Levy HL
Pediatric emergency care 2018; (34(1)):64-67 doi:10.1097/PEC.0000000000001299.
PMID: 29095391 - 6
Is it Pompe Disease? Australian diagnostic considerations.
Tchan M, Henderson R, Kornberg A, et al.
Neuromuscular disorders : NMD 2020; (30(5)):389-399 doi:10.1016/j.nmd.2020.03.007.
PMID: 32418839 - 7
Emergency Management of Inherited Metabolic Disorders in Acute Surgical and Trauma Settings.
Furuta Y, Tinker RJ, Grochowsky AR, Phillips JA
The American surgeon 2026; (92(5)):1463-1472 doi:10.1177/00031348251403079.
PMID: 41275486 - 8
Acute Illness Protocol for Organic Acidemias: Methylmalonic Acidemia and Propionic Acidemia.
Aldubayan SH, Rodan LH, Berry GT, Levy HL
Pediatric emergency care 2017; (33(2)):142-146 doi:10.1097/PEC.0000000000001028.
PMID: 28141776 - 9
Natural history of cardiac findings in mucopolysaccharidosis type I: report from an international registry.
Braunlin E, Bay L, Guffon N, et al.
Cardiology in the young 2024; (34(2)):401-411 doi:10.1017/S1047951123003347.
PMID: 37850463 - 10
Progressive heart disease in mucopolysaccharidosis type I mice may be mediated by increased cathepsin B activity.
Baldo G, Tavares AM, Gonzalez E, et al.
Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology 2017; (27()):45-50 doi:10.1016/j.carpath.2017.01.001.
PMID: 28104572 - 11
Dilated Optic Nerve Sheath in Mucopolysaccharidosis I: Common and Not Necessarily High Intracranial Pressure.
Huang S, Lund T, Orchard P, et al.
AJNR. American journal of neuroradiology 2023; (44(1)):91-94 doi:10.3174/ajnr.A7755.
PMID: 36581456 - 12
Mucopolysaccharidosis Type I and Bilateral Optic Disc Edema.
Gratton SM, Neerukonda T
Neuro-ophthalmology (Aeolus Press) 2019; (43(6)):394-396 doi:10.1080/01658107.2018.1520903.
PMID: 32165899 - 13
Hearing Loss in Mucopolysaccharidoses: Current Knowledge and Future Directions.
Wolfberg J, Chintalapati K, Tomatsu S, Nagao K
Diagnostics (Basel, Switzerland) 2020; (10(8)) doi:10.3390/diagnostics10080554.
PMID: 32759694 - 14
Markedly Elevated Intracranial Pressure Treated With Cranial Vault Expansion, Instead of CSF Shunting, in a Child With Hurler-Scheie Syndrome and Multiple Suture Craniosynostosis.
Ching JA, Troy JS, Ruas EJ, et al.
The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association 2019; (56(3)):395-399 doi:10.1177/1055665618777906.
PMID: 29791186 - 15
Enzyme replacement therapy with laronidase (Aldurazyme®) for treating mucopolysaccharidosis type I.
Jameson E, Jones S, Remmington T
The Cochrane database of systematic reviews 2019; (6()):CD009354 doi:10.1002/14651858.CD009354.pub5.
PMID: 31211405 - 16
Progressive Hand Stiffness and Numbness in a Child: An Atypical Neurological Presentation of Scheie Syndrome-A Case Report.
Alharthi AS, Hassan CI, Alsharkawy AA, et al.
Neurology international 2025; (17(12)) doi:10.3390/neurolint17120205.
PMID: 41441225 - 17
Cardiac manifestations and effects of enzyme replacement therapy for over 10 years in adults with the attenuated form of mucopolysaccharidosis type I.
Sugiura K, Kubo T, Ochi Y, et al.
Molecular genetics and metabolism reports 2020; (25()):100662 doi:10.1016/j.ymgmr.2020.100662.
PMID: 33101981 - 18
Clinical and Molecular Characterization of Patients with Mucopolysaccharidosis Type I in an Algerian Series.
Tebani A, Zanoutene-Cheriet L, Adjtoutah Z, et al.
International journal of molecular sciences 2016; (17(5)).
PMID: 27196898 - 19
Urgent resection of a giant left atrial appendage aneurysm and mitral valve replacement in a complex case of Hurler-Scheie syndrome.
Brazier A, Hasan R, Jenkins P, Hoschtitzky A
BMJ case reports 2015; (2015()).
PMID: 26546621 - 20
Successful treatment of corneal hypertrophic scar in Hurler syndrome.
Koosha N, Irajpour M, Rostamiyan Z, et al.
Clinical case reports 2024; (12(7)):e9112 doi:10.1002/ccr3.9112.
PMID: 38919886 - 21
Mucopolysaccharidosis Type I.
Kubaski F, de Oliveira Poswar F, Michelin-Tirelli K, et al.
Diagnostics (Basel, Switzerland) 2020; (10(3)) doi:10.3390/diagnostics10030161.
PMID: 32188113 - 22
Chiari I malformation and syringomyelia in mucopolysaccharidosis type I (Hurler syndrome) treated with posterior fossa decompression: Case report and review of the literature.
Makler V, Goldstein CL, Hoernschemeyer D, Tanaka T
Surgical neurology international 2017; (8()):80 doi:10.4103/sni.sni_463_16.
PMID: 28607814 - 23
Transcranial pulsed ultrasound facilitates brain uptake of laronidase in enzyme replacement therapy for Mucopolysaccharidosis type I disease.
Hsu YH, Liu RS, Lin WL, et al.
Orphanet journal of rare diseases 2017; (12(1)):109 doi:10.1186/s13023-017-0649-6.
PMID: 28595620 - 24
Mucopolysaccharidoses Causing Valvular Heart Disease: Report and Review of Surgical Management.
Encarnacion CO, Hang D, Earing M, Mitchell ME
World journal for pediatric & congenital heart surgery 2020; (11(4)):NP22-NP24 doi:10.1177/2150135117690105.
PMID: 28421916
This page provides educational information about building a care team for children with MPS I. Always consult your child's metabolic geneticist or complex care coordinator for personalized medical advice and exact surveillance schedules.
Get notified when new evidence is published on Mucopolysaccharidosis type 1.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.